Junevity
Junevity is a biotechnology company developing cell reset therapeutics for longevity. Their RESET platform uses large-scale human data and AI to identify transcription factor targets and repress them with siRNA therapeutics, initially focusing on Type 2 diabetes, obesity, and frailty.
Funding Round: Seed
Funding Amount: $10M
Date: 13-Feb-2025
Investors: Goldcrest Capital, Godfrey Capital
Markets: Biotech, Therapeutics, Longevity, Biotechnology Research, Medical, Pharmaceutical
HQ: San Francisco, California, United States
Founded: 2023
Website: https://www.junevity.com
LinkedIn: https://www.linkedin.com/company/junevity
Twitter: https://twitter.com/junevity
Crunchbase: https://www.crunchbase.com/organization/junevity
Leave a Comment
Comments
No comments yet.